Lupin Ltd
Lupin is engaged in the business of Manufacture of Pharmaceuticals.
- Market Cap ₹ 48,945 Cr.
- Current Price ₹ 1,079
- High / Low ₹ 1,122 / 505
- Stock P/E
- Book Value ₹ 280
- Dividend Yield 0.56 %
- ROCE 9.23 %
- ROE -3.58 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
Cons
- Stock is trading at 3.85 times its book value
- The company has delivered a poor sales growth of 3.78% over past five years.
- Company has a low return on equity of 1.38% for last 3 years.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3,976 | 4,034 | 3,856 | 3,951 | 3,947 | 3,887 | 3,878 | 3,882 | 3,769 | 3,846 | 3,528 | 3,835 | |
3,287 | 3,325 | 3,329 | 3,401 | 3,266 | 3,107 | 3,131 | 3,242 | 3,340 | 3,320 | 3,040 | 3,254 | |
Operating Profit | 688 | 709 | 527 | 550 | 682 | 779 | 747 | 641 | 429 | 525 | 488 | 581 |
OPM % | 17% | 18% | 14% | 14% | 17% | 20% | 19% | 16% | 11% | 14% | 14% | 15% |
Other Income | 29 | -1,318 | 185 | 231 | -291 | 115 | 106 | -359 | -161 | 293 | 44 | 25 |
Interest | 54 | 59 | 69 | 74 | 78 | 84 | 84 | 83 | 89 | 107 | 44 | 34 |
Depreciation | 280 | 273 | 259 | 265 | 219 | 219 | 250 | 253 | 253 | 214 | 215 | 213 |
Profit before tax | 383 | -941 | 384 | 441 | 93 | 591 | 518 | -54 | -73 | 496 | 273 | 360 |
Tax % | 42% | 17% | 47% | 39% | 264% | 50% | 42% | -129% | -1,046% | 21% | 60% | 41% |
Net Profit | 222 | -784 | 203 | 266 | -152 | 290 | 303 | -127 | -835 | 390 | 107 | 211 |
EPS in Rs | 4.91 | -17.33 | 4.48 | 5.88 | -3.35 | 6.40 | 6.70 | -2.81 | -18.44 | 8.60 | 2.36 | 4.66 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3,776 | 4,774 | 5,819 | 7,083 | 9,641 | 11,286 | 12,770 | 14,256 | 17,367 | 15,797 | 14,665 | 15,375 | 14,978 | |
3,124 | 3,887 | 4,634 | 5,621 | 7,356 | 8,272 | 9,146 | 10,570 | 12,866 | 12,712 | 12,131 | 13,127 | 12,954 | |
Operating Profit | 652 | 887 | 1,185 | 1,461 | 2,284 | 3,014 | 3,624 | 3,685 | 4,501 | 3,085 | 2,534 | 2,248 | 2,024 |
OPM % | 17% | 19% | 20% | 21% | 24% | 27% | 28% | 26% | 26% | 20% | 17% | 15% | 14% |
Other Income | 92 | 111 | 15 | -2 | 13 | 105 | 236 | 190 | 107 | -1,248 | 118 | -27 | 201 |
Interest | 50 | 38 | 34 | 35 | 41 | 27 | 10 | 59 | 153 | 204 | 302 | 363 | 274 |
Depreciation | 88 | 124 | 171 | 228 | 332 | 261 | 435 | 487 | 912 | 1,086 | 846 | 970 | 895 |
Profit before tax | 606 | 836 | 994 | 1,196 | 1,925 | 2,832 | 3,415 | 3,329 | 3,543 | 547 | 1,503 | 887 | 1,056 |
Tax % | 16% | 16% | 12% | 26% | 30% | 34% | 28% | 32% | 28% | 53% | 59% | 130% | |
Net Profit | 502 | 682 | 863 | 868 | 1,314 | 1,836 | 2,403 | 2,261 | 2,557 | 251 | 607 | -269 | -127 |
EPS in Rs | 12.11 | 15.33 | 19.33 | 19.43 | 29.36 | 40.96 | 53.47 | 50.17 | 56.63 | 5.56 | 13.40 | -5.95 | -2.82 |
Dividend Payout % | 21% | 18% | 16% | 18% | 14% | 15% | 14% | 15% | 13% | 90% | 37% | -101% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 4% |
3 Years: | -4% |
TTM: | -4% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -599% |
Stock Price CAGR | |
---|---|
10 Years: | 9% |
5 Years: | -9% |
3 Years: | 4% |
1 Year: | 46% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 9% |
3 Years: | 1% |
Last Year: | -4% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
83 | 89 | 89 | 89 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 91 | 91 | |
Reserves | 1,342 | 2,479 | 3,192 | 3,924 | 5,115 | 6,842 | 8,784 | 11,073 | 13,407 | 13,487 | 13,652 | 12,446 | 12,626 |
Borrowings | 1,223 | 1,140 | 1,162 | 1,639 | 1,164 | 654 | 537 | 7,178 | 7,966 | 7,143 | 8,496 | 6,305 | 2,456 |
1,347 | 1,358 | 1,643 | 2,283 | 2,475 | 2,550 | 3,642 | 3,957 | 4,749 | 5,300 | 5,423 | 5,968 | 7,529 | |
Total Liabilities | 3,995 | 5,066 | 6,086 | 7,935 | 8,843 | 10,135 | 13,054 | 22,298 | 26,212 | 26,020 | 27,661 | 24,810 | 22,703 |
1,519 | 1,906 | 2,057 | 2,750 | 3,000 | 3,356 | 4,368 | 8,717 | 11,033 | 10,362 | 11,087 | 7,938 | 7,938 | |
CWIP | 224 | 358 | 490 | 444 | 311 | 304 | 576 | 2,702 | 2,133 | 2,598 | 1,640 | 940 | 941 |
Investments | 22 | 26 | 3 | 3 | 2 | 178 | 1,658 | 16 | 2,136 | 262 | 2,295 | 2,374 | 1,276 |
2,231 | 2,775 | 3,536 | 4,739 | 5,530 | 6,297 | 6,451 | 10,862 | 10,910 | 12,798 | 12,639 | 13,557 | 12,548 | |
Total Assets | 3,995 | 5,066 | 6,086 | 7,935 | 8,843 | 10,135 | 13,054 | 22,298 | 26,212 | 26,020 | 27,661 | 24,810 | 22,703 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
470 | 676 | 798 | 560 | 1,251 | 2,004 | 2,733 | -382 | 4,114 | 1,751 | 1,666 | 1,469 | |
-505 | -683 | -520 | -720 | -522 | -851 | -1,034 | -6,769 | -2,527 | 470 | -3,282 | 1,107 | |
-167 | 136 | -163 | 109 | -663 | -857 | -197 | 5,836 | 433 | -1,492 | 744 | -891 | |
Net Cash Flow | -203 | 130 | 116 | -51 | 66 | 296 | 1,502 | -1,315 | 2,019 | 729 | -872 | 1,685 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 26% | 27% | 25% | 25% | 33% | 41% | 40% | 24% | 19% | 10% | 10% | 9% |
Debtor Days | 89 | 86 | 79 | 92 | 83 | 80 | 76 | 116 | 91 | 120 | 128 | 129 |
Inventory Turnover | 2.00 | 2.20 | 2.25 | 1.96 | 2.10 | 2.04 | 1.95 | 1.63 | 1.56 | 1.56 | 1.44 | 1.61 |
Documents
Add documentRecent announcements
- Shareholding for the Period Ended December 31, 2020 19 Jan
- Statement Of Investor Complaints For The Quarter Ended December 2020 19 Jan
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 18 Jan
- Announcement under Regulation 30 (LODR)-Investor Presentation 12 Jan
- Board Meeting Intimation for Considering And Taking On Record Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2020. 12 Jan
View all
Annual reports
- Financial Year 2020 from bse
- Financial Year 2019 from bse
- Financial Year 2018 from bse
- Financial Year 2017 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse
- Financial Year 2014 from bse
- Financial Year 2013 from bse
- Financial Year 2012 from bse
- Financial Year 2012 from nse
- Financial Year 2011 from bse
- Financial Year 2010 from bse